Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Eyenovia Inc

EYEN
Current price
0.63 USD +0.0088 USD (+1.41%)
Last closed 0.62 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 37 170 852 USD
Yield for 12 month -75.16 %
1Y
3Y
5Y
10Y
15Y
EYEN
21.11.2021 - 28.11.2021

Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York. Address: 295 Madison Avenue, New York, NY, United States, 10017

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9 USD

P/E ratio

Dividend Yield

Current Year

+3 787 USD

Last Year

+10 000 000 USD

Current Quarter

+4 993 USD

Last Quarter

+2 589 USD

Current Year

-783 208 USD

Last Year

-307 430 USD

Current Quarter

-331 460 USD

Last Quarter

-277 524 USD

Key Figures EYEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -29 246 616 USD
Operating Margin TTM -205624.37 %
PE Ratio
Return On Assets TTM -68.07 %
PEG Ratio
Return On Equity TTM -368.02 %
Wall Street Target Price 9 USD
Revenue TTM 8 780 USD
Book Value 0.038 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 400 %
Dividend Yield
Gross Profit TTM 12 400 000 USD
Earnings per share -0.74 USD
Diluted Eps TTM -0.74 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics EYEN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EYEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EYEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 6957.0304
Price Sales TTM 6631.8296
Enterprise Value EBITDA -1.0929
Price Book MRQ 2.7908

Financials EYEN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EYEN

For 52 weeks

0.5 USD 2.81 USD
50 Day MA 0.74 USD
Shares Short Prior Month 5 533 364
200 Day MA 1.4 USD
Short Ratio 4.25
Shares Short 4 029 443
Short Percent 11.56 %

Dynamics of changes in the value of assets

Stocks


AAPL

AAPL

212.49 USD Apple Inc -1.32 (-0.62%)
Detailed analytics

ETF funds


S

SX7EEX

13.36 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) -0.53 (-3.54%)
Detailed analytics

Metals


Gold

2332.52 USD Gold +27.54 (+1.2%)
Detailed analytics